MapLight to discuss autism drug’s future with FDA after Phase 2 missnews2026-06-22T15:17:54+00:00June 22nd, 2026|Endpoints News|
Lilly allies with BioArctic; Antengene and Insilico sign dealsnews2026-06-22T15:07:19+00:00June 22nd, 2026|Endpoints News|
Merck’s IBD drug from $10.8B Prometheus deal claims its first Phase 3 winnews2026-06-22T14:32:49+00:00June 22nd, 2026|Endpoints News|
Evonik to cut a further 3200 jobs by 2029news2026-06-22T14:04:00+00:00June 22nd, 2026|Chemistry World|
Molecular labels streamline high throughput mass spec analysis by rapidly ranking reactionsnews2026-06-22T13:30:00+00:00June 22nd, 2026|Chemistry World|
Post-Hoc Live: Are the China hawks winning?news2026-06-22T12:46:32+00:00June 22nd, 2026|Endpoints News|
Regenxbio to resubmit Hunter syndrome gene therapy without new studynews2026-06-22T11:14:56+00:00June 22nd, 2026|Endpoints News|
